Updates in Structural Cardiovascular Interventions: Key Insights from Recent Studies
- PMID: 39458065
- PMCID: PMC11508871
- DOI: 10.3390/jcm13206115
Updates in Structural Cardiovascular Interventions: Key Insights from Recent Studies
Abstract
The year 2024 brought remarkable advancements and high-quality evidence to the field of cardiovascular interventions [...].
Conflict of interest statement
Tagliari received speaking fees from Boston Scientific, and Meril Life. Taramasso has been a consultant or the recipient of consultancy fees from Abbott, Edwards Lifesciences, Boston Scientific, Shenqi Medical, Coremedic, 4tech, Simulands, MTEX, Cardiovalve, and Medira.
References
-
- Thyregod H.G.H., Jørgensen T.H., Ihlemann N., Steinbrüchel D.A., Nissen H., Kjeldsen B.J., Petursson P., De Backer O., Olsen P.S., Søndergaard L. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur. Heart J. 2024;45:1116–1124. doi: 10.1093/eurheartj/ehae043. - DOI - PMC - PubMed
-
- Jørgensen T.H., Thyregod H.G.H., Savontaus M., Willemen Y., Bleie Ø., Tang M., Niemela M., Angerås O., Gudmundsdóttir I.J., Sartipy U., et al. Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial. Eur. Heart J. 2024;45:3804–3814. doi: 10.1093/eurheartj/ehae331. - DOI - PubMed
-
- Eltchaninoff H. RHEIA—Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis; Proceedings of the ESC 2024; London, UK. 31 August 2024.
Publication types
LinkOut - more resources
Full Text Sources
